Crossmark

The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer

Crossref DOI link: https://doi.org/10.1186/s40880-019-0367-7

Published Online: 2019-05-08

Published Print: 2019-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Wang, Zhi‐Qiang

Zhang, Fei

Deng, Ting

Zhang, Le

Feng, Fen

Wang, Feng‐Hua

Wang, Wei

Wang, De‐Shen

Luo, Hui‐Yan

Xu, Rui‐Hua

Ba, Yi

Li, Yu‐Hong
License Information

Version of Record valid from 2019-05-08
More Information

Publication History

Received: 2018-09-19

Accepted: 2019-04-15

Published: 2019-05-08